Photo from ESTROL/LinkedIn
Aug 15, 2024, 18:54
ESTRO24 Highlights in radiobiology and SBRT
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn:
“ESTRO24 Highlights in radiobiology and SBRT:
- Isotoxic doses in pancreatic cancer
- Genetic insights into breast cancer radioresistance
- STAT3 inhibition for brain metastases radionecrosis
- Synergy of radiotherapy and immunotherapy
- Hypofractionation benefits and challenges.”
Source: ESTRO/LinkedIn
More posts by ESTRO in OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 16:29
Nov 14, 2024, 16:27
Nov 14, 2024, 16:22
Nov 14, 2024, 16:22
Nov 14, 2024, 16:13
Nov 14, 2024, 16:03
Nov 14, 2024, 15:58
Nov 14, 2024, 15:54
Nov 14, 2024, 15:53